ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 361605 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 361605; 2) Community: the network communities that were significantly associated with the response to NSC 361605; 3) Molecule: the relationships between components within communities and NSC 361605; 4) MDR: the compounds that were significantly associated with the NSC 361605.

NSC Compound Enrichment Correlation
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0208632511155816 0.18537824
NSC 728220 1-(3-Bromo-phenyl)-3-(pyridin-2-ylsulfanyl)-propenone 0.0208632511155816 0.40445079
NSC 730563 Miliusane A 0.0208632511155816 0.27345798
NSC 734562 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride 0.0208632511155816 0.34567097
NSC 735318 Null 0.0208632511155816 0.25212316
NSC 736164 pyrazoline derivative 0.0208632511155816 0.22028824
NSC 737613 Null 0.0208632511155816 0.37490873
NSC 740504 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0208632511155816 0.20964994
NSC 169774 Bromocriptine methanesulfonate 0.0208632511155817 0.38173342
NSC 20200 [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride 0.0208632511155817 0.13702163
Total:79  Current:38    [First] [Prev] [Next] [Last]